Antimicrobial Activity of a Triple Antibiotic Combination Toward Ocular Pseudomonas aeruginosa Clinical Isolates

PURPOSE: Pseudomonas aeruginosa is a leading cause of corneal infections. Recently, we discovered an antimicrobial drug combination, polymyxin B/trimethoprim (PT) + rifampin, that displayed impressive efficacy toward P. aeruginosa in both in vitro and in vivo studies. As such, this combination was f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Jia A., Johnson, William, Kinn, Bailey, Laskey, Emily, Nolin, Lydia, Bhamare, Pratham, Stalker, Charlotte, Dunman, Paul M., Wozniak, Rachel A. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145016/
https://www.ncbi.nlm.nih.gov/pubmed/35612831
http://dx.doi.org/10.1167/tvst.11.5.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145016/
https://www.ncbi.nlm.nih.gov/pubmed/35612831
http://dx.doi.org/10.1167/tvst.11.5.26

Ejemplares similares